Newsroom | 42645 results

NUEVA YORK--(BUSINESS WIRE)--Blue Matter tiene el orgullo de anunciar que ha establecido un área de práctica que prestará exclusivamente servicios a los clientes en investigación y desarrollo (I+D) biofarmacéutico. La dirección de esta práctica estará a cargo de Tara Austraat-Churik, una socia que se incorporó a la firma en septiembre de 2025. Tara Austraat-Churik tiene más de 20 años de experiencia en servicios a los clientes del sector de las ciencias de la vida. Se ha especializado en las ár...

NEW YORK--(BUSINESS WIRE)--Blue Matter a le plaisir d'annoncer la création d'un domaine d'expertise dédié aux clients du secteur de la recherche et développement biopharmaceutique. Ce domaine est dirigé par l'associée Tara Austraat-Churik, qui a rejoint le cabinet en septembre 2025. Tara Austraat-Churik accompagne les acteurs des sciences de la vie depuis plus de 20 ans. Ses domaines d'expertise comprennent le développement et la mise en œuvre de stratégies, la conception de modèles opérationne...

NEW YORK--(BUSINESS WIRE)--Blue Matter annuncia la creazione di una nuova area di consulenza dedicata ai clienti del settore R&S biofarmaceutico e diretta da Tara Austraat-Churik, partner unitasi a Blue Matter nel settembre 2025. Tara Austraat-Churik vanta un’esperienza di oltre 20 anni al servizio di clienti nel settore delle scienze della vita. Molteplici le sue aree di competenza – sviluppo e implementazione di strategie, progettazione di modelli operativi e organizzativi, ottimizzazione...

NEW YORK--(BUSINESS WIRE)--Blue Matter hat einen neuen Praxisbereich gegründet, der auf die Bedürfnisse von Kunden aus der biopharmazeutischen Forschung und Entwicklung (FuE) ausgerichtet ist. Geleitet wird der Praxisbereich von Tara Austraat-Churik, einer Partnerin, die seit September 2025 für Blue Matter tätig ist. Tara Austraat-Churik ist bereits seit über 20 Jahren für Life-Science-Kunden tätig. Ihre Schwerpunkte sind Strategieentwicklung und -umsetzung, Betriebsmodell- und Organisationsges...

GAINESVILLE, Fla.--(BUSINESS WIRE)--Orthopedic Care Partners (OCP) welcomes Rob Passaro as Vice President of Business Development. His appointment supports OCP’s ongoing growth initiatives, strengthens its market presence, and contributes to building long-term value with physician partners. Passaro brings nearly twenty years of healthcare and business development expertise, having held leadership roles within high-growth, physician-led, and private equity-backed organizations. His experience in...

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services (NYSE: GRDN), one of the nation’s leading long-term care (“LTC”) pharmacy services companies, is reiterating its previously announced 2025 guidance and providing its preliminary financial outlook for 2026. The Company expects to continue its low double-digit adjusted EBITDA growth trajectory in 2026, supported by the strength of its operating model and increased visibility into the year ahead, including anticipated drug pricing changes. The C...

SAN FRANCISCO--(BUSINESS WIRE)--On the occasion of the 44th J.P. Morgan Healthcare Conference in San Francisco, Bayer AG today unveiled the strategic focus for its Pharmaceuticals Division in 2026. Capitalizing on new launch momentum, the company will drive significant global regulatory expansions and market penetration across its pharmaceutical portfolio. High-value commercial products and an accelerating modality-rich pipeline across oncology, cardiology, neurology, and immunology have firmly...

NEW YORK--(BUSINESS WIRE)--After several years of constrained capital markets and heightened investor caution, the healthcare venture ecosystem began to stabilize in 2025, setting the stage for a more constructive, though still selective, environment heading into 2026, according to HSBC Innovation Banking’s 2026 Venture Healthcare Outlook. The downturn that followed the post-pandemic peak was marked by slower investment pace, limited IPO activity, and an increase in insider-led financings. Whil...

SAN FRANCISCO--(BUSINESS WIRE)--Animate Bio reports positive preclinical data showing two AI-designed peptides reduced lung fibrosis & inflammation, with the lead matching nintedanib...

SAN FRANCISCO--(BUSINESS WIRE)--Bunkerhill Health today announced the system-wide deployment of its Carebricks platform at the University of Texas Medical Branch, enabling clinician-led, agentic AI workflows that support care delivery across a health system serving over one million patient visits annually. Over the past year, UTMB Health has moved beyond isolated AI initiatives by deploying Bunkerhill’s Carebricks platform to translate clinician- and operator-led ideas into system-wide action....